Skip to main content
SpringerLink
Log in

Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

To assess the efficacy of long-term treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on bone marrow oedema (BMO) of the sacroiliac joint in newly diagnosed axial spondyloarthritis (SpA) with a symptom duration of less than 4 years, a single-center, open-label study in a cohort of consecutive patients with newly diagnosed axial SpA was conducted. Eligible patients had magnetic resonance imaging (MRI)-determined BMO of the sacroiliac joint at baseline, had a symptom duration of less than 4 years, and were naïve to NSAIDs. After the baseline MRI, an optimal dose of NSAID was administered for 24 or 48 weeks. BMO of sacroiliac joint was quantified by applying the Spondyloarthritis Research Consortium of Canada (SPARCC) system. Disease activity was expressed using the Ankylosing Spondylitis Disease Activity Score (ASDAS). Primary end points were improvement in BMO of sacroiliac joint at week 24 or week 48. Forty-three patients were recruited, and 33 patients eventually completed the study, including 10 patients having follow-up MRI at week 24 and 23 patients having follow-up MRI at week 48. Overall, the mean of SPARCC score decreased from 21.8 ± 16.1 at baseline to 10.2 ± 12.8 at follow-up (p < 0.001). 75.8% of the patients displayed a minimally important change, and 30.3% became free of BMO. The mean of ASDAS-CRP decreased from 3.1 ± 1.0 at baseline to 2.1 ± 1.0 at follow-up (p < 0.001). Long-term treatment with optimal dose NSAIDs could significantly alleviate BMO of sacroiliac joint in early and active axial SpA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AS:

Ankylosing spondylitis

ASAS:

Assessment of SpondyloArthritis international Society

ASDAS:

Ankylosing Spondylitis Disease Activity Score

Anti-TNF:

Anti-tumor necrosis factor

BMO:

Bone marrow oedema

CII:

Clinically important improvement

CRP:

C-reactive protein

ESR:

Erythrocyte sedimentation rate

ID:

Inactive disease

MI:

Major improvement

MIC:

Minimally important change

MRI:

Magnetic resonance imaging

NSAIDs:

Nonsteroidal antiinflammatory drugs

SpA:

Spondyloarthritis

SPARCC:

Spondyloarthritis Research Consortium of Canada

References

  1. Hermann KG, Baraliakos X, van der Heijde DM et al (2012) Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group. Ann Rheum Dis 71(8):1278–1288

    Article  PubMed  Google Scholar 

  2. Braun J, Bollow M, Eggens U et al (1994) Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 37(7):1039–1045

    Article  CAS  PubMed  Google Scholar 

  3. Bollow M, Fischer T, Reisshauer H et al (2000) Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 59(2):135–140

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Oostveen J, Prevo R, den Boer J et al (1999) Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J Rheumatol 26(9):1953–1958

    CAS  PubMed  Google Scholar 

  5. Sieper J, Rudwaleit M, Baraliakos X et al (2009) The assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–i44

    Article  PubMed  Google Scholar 

  6. Lambert RG, Bakker PA, van der Heijde D et al (2016) Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis 75:1958–1963

    Article  PubMed  Google Scholar 

  7. Rudwaleit M, Jurik AG, Hermann KG et al (2009) Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 68(10):1520–1527

    Article  CAS  PubMed  Google Scholar 

  8. Braun J, van den Berg R, Baraliakos X et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70(6):896–904

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ward MM, Deodhar A, Akl EA et al (2016) American College of Rheumatology/spondylitis Association of America/Spondyloarthritis research and treatment network 2015 recommendations for the treatment of ankylosing spondylitis and Nonradiographic axial Spondyloarthritis. Arthritis Care Res (Hoboken) 68(2):151–166

    Article  Google Scholar 

  10. Wanders A, Dv H, Landewé R et al (2005) Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 52(6):1756–1765

    Article  CAS  PubMed  Google Scholar 

  11. Dougados M, Simon P, Braun J et al (2011) ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis 70(2):249–251

    Article  CAS  PubMed  Google Scholar 

  12. Maksymowych WP, Inman RD, Salonen D et al (2005) Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 53(5):703–709

    Article  PubMed  Google Scholar 

  13. Kroon F, Landewé R, Dougados M et al (2012) Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 71(10):1623–1629

    Article  CAS  PubMed  Google Scholar 

  14. Varkas G, Jans L, Cypers H et al (2016) Brief report: six-week treatment of axial Spondyloarthritis patients with an optimal dose of nonsteroidal Antiinflammatory drugs: early response to treatment in signal intensity on magnetic resonance imaging of the sacroiliac joints. Arthritis Rheumatol 68(3):672–678

    Article  CAS  PubMed  Google Scholar 

  15. Barkham N, Keen HI, Coates LC et al (2009) Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 60(4):946–954

    Article  CAS  PubMed  Google Scholar 

  16. Sieper J, Lenaerts J, Wollenhaupt J et al (2014) Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, part 1. Ann Rheum Dis 73(1):101–107

    Article  CAS  PubMed  Google Scholar 

  17. Dougados M, Gueguen A, Nakache JP et al (1999) Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology (Oxford) 38(3):235–244

    Article  CAS  Google Scholar 

  18. van Onna M, van Tubergen A, Jurik AG et al (2015) Natural course of bone marrow oedema on magnetic resonance imaging of the sacroiliac joints in patients with early inflammatory back pain: a 2-year follow-up study. Scand J Rheumatol 44(2):129–134

    Article  PubMed  Google Scholar 

  19. Lambert RG, Salonen D, Rahman P et al (2007) Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 56(12):4005–4014

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We wish to thank all patients who participated in this study.

Author information

Author notes

  1. Mei Tang and Leixi Xue contributed equally to this work.

Authors and Affiliations

  1. Department of Rheumatology and Immunology, the Second Affiliated Hospital of Soochow University, Suzhou, China

    Mei Tang, Leixi Xue, Lin Bo, Ru Yang, Jian Wen, Yi Zhang & Zhichun Liu

  2. Department of Epidemiology and Medical Statistics, School of Public Health, Medical College of Soochow University, Suzhou, China

    Yueping Shen

  3. Department of Hematology, the Second Affiliated Hospital of Soochow University, Suzhou, China

    Jinxiang Fu

  4. the Second Affiliated Hospital of Soochow University, Sanxiang Road No.1055, Suzhou, Jiangsu, 215000, People’s Republic of China

    Zhichun Liu & Jinxiang Fu

Authors
  1. Mei Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leixi Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yueping Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lin Bo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ru Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jian Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhichun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jinxiang Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Zhichun Liu or Jinxiang Fu.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, M., Xue, L., Shen, Y. et al. Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients. Clin Rheumatol 37, 245–250 (2018). https://doi.org/10.1007/s10067-017-3666-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3666-x

Keywords

Search

Navigation